| Product Code: ETC8869819 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Poland Patented Drugs Market Overview |
3.1 Poland Country Macro Economic Indicators |
3.2 Poland Patented Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Poland Patented Drugs Market - Industry Life Cycle |
3.4 Poland Patented Drugs Market - Porter's Five Forces |
3.5 Poland Patented Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.6 Poland Patented Drugs Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.7 Poland Patented Drugs Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 Poland Patented Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Poland |
4.2.2 Government initiatives to improve healthcare infrastructure |
4.2.3 Rising disposable income leading to higher spending on healthcare |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval process for patented drugs |
4.3.2 Competition from generic drug manufacturers |
4.3.3 Price control measures implemented by the government |
5 Poland Patented Drugs Market Trends |
6 Poland Patented Drugs Market, By Types |
6.1 Poland Patented Drugs Market, By Distribution Channel |
6.1.1 Overview and Analysis |
6.1.2 Poland Patented Drugs Market Revenues & Volume, By Distribution Channel, 2021- 2031F |
6.1.3 Poland Patented Drugs Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.1.4 Poland Patented Drugs Market Revenues & Volume, By Drug Store and Retail Pharmacies, 2021- 2031F |
6.1.5 Poland Patented Drugs Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.2 Poland Patented Drugs Market, By Dosage Form |
6.2.1 Overview and Analysis |
6.2.2 Poland Patented Drugs Market Revenues & Volume, By Solid Drug Product, 2021- 2031F |
6.2.3 Poland Patented Drugs Market Revenues & Volume, By Liquid Drug Product, 2021- 2031F |
6.2.4 Poland Patented Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Poland Patented Drugs Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Poland Patented Drugs Market Revenues & Volume, By Cardiovascular Diseases, 2021- 2031F |
6.3.3 Poland Patented Drugs Market Revenues & Volume, By Cancer, 2021- 2031F |
6.3.4 Poland Patented Drugs Market Revenues & Volume, By Autoimmune Diseases, 2021- 2031F |
6.3.5 Poland Patented Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 Poland Patented Drugs Market Import-Export Trade Statistics |
7.1 Poland Patented Drugs Market Export to Major Countries |
7.2 Poland Patented Drugs Market Imports from Major Countries |
8 Poland Patented Drugs Market Key Performance Indicators |
8.1 Research and development investment in patented drugs |
8.2 Number of patents granted for new drugs in Poland |
8.3 Adoption rate of innovative patented drugs by healthcare providers |
8.4 Average time taken for drug approval process in Poland |
8.5 Number of clinical trials conducted for patented drugs in the market |
9 Poland Patented Drugs Market - Opportunity Assessment |
9.1 Poland Patented Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.2 Poland Patented Drugs Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.3 Poland Patented Drugs Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Poland Patented Drugs Market - Competitive Landscape |
10.1 Poland Patented Drugs Market Revenue Share, By Companies, 2024 |
10.2 Poland Patented Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here